Bristol-Myers says it won't sue drug maker
Bristol-Myers Squibb Co., responding to criticism over the high price of its AIDS drugs in poor countries, could become the first big pharmaceutical company formally to allow a generic-drug maker to
Bristol-Myers Squibb Co., responding to criticism over the high price of its AIDS drugs in poor countries, could become the first big pharmaceutical company formally to allow a generic-drug maker to